Skip to main content

Table 1 Dominant transforming growth factor-β gene signatures in the luminal MCF-7 CN and MCF-7 H2 cell lines

From: HER-2 overexpression differentially alters transforming growth factor-β responses in luminal versus mesenchymal human breast cancer cells

Sequence namea

Sequence descriptionb

Fold Δ MCF-7 CNc

Fold Δ MCF-7 H2d

Gene ontologye

TGF-β induced genes

    

   BCL3

B-cell chronic lymphocytic Leukemia (CLL)/lymphoma 3

1.70

 

Cell cycle

   BACE

Beta-site amyloid precursor protein (APP)-cleaving enzyme

2.86

 

ECM/adhesion

   CD59

CD59 antigen p18-20

1.74 (3)

 

ECM/adhesion

   CDH11

Cadherin 11, type 2, OB-cadherin (osteoblast)

1.94

 

ECM/adhesion

   COL18A1

Collagen, type XVIII, alpha 1

1.91

 

ECM/adhesion

   COL5A1

Collagen, type V, alpha 1

5.01 (2)

4.22 (2)

ECM/adhesion

   IGSF4

Immunoglobulin superfamily, member 4

1.94

1.81

ECM/adhesion

   SCARB1

Scavenger receptor class B, member 1

1.77

 

ECM/adhesion

   SPOCK

Sparc/osteonectin (testican)

8.23

 

ECM/adhesion

   THBS1

Thrombospondin 1

2.31 (3)

 

ECM/adhesion

   BMP7

Bone morphogenetic protein 7 (osteogenic protein 1)

2.05

 

Secreted factor

   IGFBP5

Insulin-like growth factor binding protein 5

4.56

 

Secreted factor

   MSMB

microseminoprotein, beta-

11.19 (2)

3.65 (2)

Secreted factor

   CBFA2T3

Core-binding factor, runt domain, alpha subunit 2

2.06

 

Transcription factor

   DZIP3

Zinc finger DAZ interacting protein 3

1.93

 

Transcription factor

   ELK3

Sapiens cDNA: FLJ22425 fis, clone HRC08686

1.90

 

Transcription factor

   FOXO1A

Forkhead box O1A (rhabdomyosarcoma)

3.45 (2)

 

Transcription factor

   MADH3

MAD, mothers against decapentaplegic homolog 3

4.77

 

Transcription factor

   NRBP

Nuclear receptor binding protein

2.12

 

Transcription factor

   PLU-1

Putative DNA/chromatin binding motif

1.75 (2)

 

Transcription factor

   SOLH

Small optic lobes homolog (Drosophila)

1.86

 

Transcription factor

   TGIF

Transforming growth factor beta (TGFB)-induced factor (TALE family homeobox)

1.70

 

Transcription factor

   TIEG

Transforming growth factor beta (TGFB) inducible early growth response

1.77

 

Transcription factor

TGF-β repressed genes

    

   BIRC5

Baculoviral inhibitor of apoptosis (IAP) repeat-containing 5 (survivin)

-3.04

 

Apoptosis

   CCNA2

Cyclin A2

-2.18

 

Cell cycle

   CCNB1

Cyclin B1

-1.99

 

Cell cycle

   CCNB2

Cyclin B2

-1.94

 

Cell cycle

   CCNE2

Cyclin E2

-2.03

 

Cell cycle

   CDC2

Cell division cycle 2, G1 to S and G2 to M

-2.62 (2)

-1.77 (2)

Cell cycle

   CDC20

CDC20 cell division cycle 20 homolog (S. cerevisiae)

-2.10

 

Cell cycle

   CDC25C

Cell division cycle 25C

-2.02

 

Cell cycle

   CDKN2C

Cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)

-2.59

 

Cell cycle

   CDKN3

Cyclin-dependent kinase inhibitor 3

-2.66

 

Cell cycle

   CKS1B

CDC28 protein kinase regulatory subunit 1B

-1.96

 

Cell cycle

   CKS2

CDC28 protein kinase regulatory subunit 2

-1.70

 

Cell cycle

   MKI67

Antigen identified by monoclonal antibody Ki-67

-2.26 (2)

-2.84

Cell cycle

   MPHOSPH9

M-phase phosphoprotein 9

-1.86

 

Cell cycle

   NEK2

NIMA (never in mitosis gene a)-related kinase 2

-2.93

 

Cell cycle

   ASPM

asp (abnormal spindle)-like, microcephaly associated

-2.48

 

Chromosome reg.

   BUB1

BUB1 budding uninhibited by benzimidazoles 1 homolog

-2.08

-1.72

Chromosome reg.

   BUB1B

BUB1 budding uninhibited by benzimidazoles 1 homolog β

-1.78

 

Chromosome reg.

   CENPA

Centromere protein A, 17 kDa

-2.53

 

Chromosome reg.

   CENPE

Centromere protein E, 312kDa

-9.38

-4.87

Chromosome reg.

   CENPF

Centromere protein F, 350/400 kDa (mitosin)

-2.42

 

Chromosome reg.

   CNAP1

Chromosome condensation-related Structural maintenance of chromosomes (SMC)-associated protein 1

-1.99

 

Chromosome reg.

   ESPL1

Extra spindle poles like 1 (S. cerevisiae)

-2.62

 

Chromosome reg.

   HCAP-G

Chromosome condensation protein G

-2.29 (2)

-1.90

Chromosome reg.

   HEC

Highly expressed in cancer, rich in leucine heptad repeats

-4.35

-2.32

Chromosome reg.

   PRC1

Protein regulator of cytokinesis 1

-2.23

 

Chromosome reg.

   SMC2L1

SMC2 structural maintenance of chromosomes 2-like 1

-3.27

-1.70

Chromosome reg.

   ZWINT

ZW10 interactor

-1.75

 

Chromosome reg.

   BARD1

BRCA1 associated RING domain 1

-1.92

 

DNA metabolism

   BRIP1

BRCA1 interacting protein C-terminal helicase 1

-1.71

 

DNA metabolism

   CDT1

DNA replication factor

-1.70

 

DNA metabolism

   PIR51

RAD51-interacting protein

-2.17

 

DNA metabolism

   POLD1

Polymerase (DNA directed), delta 1, catalytic subunit

-2.68

 

DNA metabolism

   POLE2

Polymerase (DNA directed), epsilon 2 (p59 subunit)

-1.78

 

DNA metabolism

   PRIM1

Primase, polypeptide 1, 49 kDa

-1.76

 

DNA metabolism

   RAD51C

RAD51 homolog C (S. cerevisiae)

-1.72

 

DNA metabolism

   RFC4

Replication factor C (activator 1) 4, 37 kDa

-1.72

 

DNA metabolism

   TOP2A

Topoisomerase (DNA) II alpha 170 kDa

-2.68 (2)

 

DNA metabolism

   ID1

Inhibitor of DNA binding 1, dominant negative HLH protein

-1.74

 

Transcription factor

   MXD3

MAX dimerization protein 3

-22.10

 

Transcription factor

   MYBL1

v-myb myeloblastosis viral oncogene homolog-like 1

-2.09

 

Transcription factor

   MYBL2

v-myb myeloblastosis viral oncogene homolog-like 2

-2.07

 

Transcription factor

  1. a,b The primary sequence names and descriptions for the differentially regulated genes (defined as greater or equal to 1.7-fold changed with a p-value of < 0.01) were extracted using Rosetta Resolver. Genes from the dominant ontology classes are shown and thus genes with unknown function or those not in well represented ontology classes are not listed. The complete set of differentially expressed genes can be found in Additional files 2, 3, 4, 5. c Fold change in expression of the induced or repressed genes in the MCF-7 CN cell line after a 24 h exposure to 2 ng/ml recombinant transforming growth factor (TGF)-β1 compared to the diluent treated controls. The number in parentheses after the fold change indicates the number of affected elements that were averaged to calculate the fold difference. d Fold change in expression of the induced or repressed genes in the MCF-7 H2 cell line after a 24 h exposure to 2 ng/ml recombinant TGF-β1 compared to the diluent treated controls. The number in parentheses to the right of the fold change indicates the number of affected elements that were averaged to calculate the fold difference. e The gene ontology annotation was curated from the Summary Function and GO fields downloaded from SOURCE [105].